Top Markets
Coin of the day
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Rank in Stocks #429
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health... Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Share Price
$116.36
Market Cap
$51.28B
Change (1 day)
0.37%
Change (1 year)
-27.86%
Country
US
Trade Zoetis Inc. (ZTS)

Category

Operating Margin for Zoetis Inc. (ZTS)
Operating Margin as of March 2026 TTM: 38.00%
According to Zoetis Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 38.00%. At the end of 2023 the company had an Operating Margin of 35.92%.
Operating Margin history for Zoetis Inc. from 2009 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 38.00% 3.68%
2024 36.65% 2.03%
2023 35.92% -0.88%
2022 36.24% 0.53%
2021 36.05% 6.06%
2020 33.99% 5.43%
2019 32.24% -0.15%
2018 32.29% -0.77%
2017 32.54% 13.30%
2016 28.72% 26.46%
2015 22.71% 12.04%
2014 20.27% 12.61%
2013 18.00% -8.63%
2012 19.70% 21.91%
2011 16.16% 87.25%
2010 8.63% -15.23%
2009 10.18% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
20.15% -99.47%
DE
20.30% -99.47%
FR
10.28% -99.73%
JP
253.25% -93.34%
IL
20.49% -99.46%
GB
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.